Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tamoxifen combined with vitamin C (ascorbic acid) is a therapeutic approach studied for breast cancer treatment. Research indicates that vitamin C may enhance tamoxifen's effectiveness while potentially reducing some of its side effects. The combination has shown synergistic effects in inhibiting breast cancer cell proliferation in vitro. Vitamin C appears to help reduce tamoxifen-induced hypertriglyceridemia and may work by increasing reactive oxygen species in cancer cells when administered at high doses. Studies suggest this combination may be more effective than tamoxifen alone in treating hormone-responsive breast cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tamoxifen + vitamin c.